The Parkinson’s Project
Our mission is to provide quality productions which reflect the professional standards of today’s entertainment as well as committing ourselves with pride and a strong dedication of giving generously to Parkinson’s disease research.
About Parkinson Disease
Parkinson Disease or PD - Parkinson's disease is a degenerative disorder of the central nervous system that often impairs the sufferer's motor skills and speech. Click here to hear Carol Meenen's PD Story
Latest News
Songs of Love And Hope CD. The songs were created from poetry by Carol Meenen. Andre Clark composed the awesome music on the CD of PD.
Join Us on Facebook | Our Mailing List
Love And Best Wishes
This is the first poem Carol Meenen sent to Andre Clark. This is the song that started it all! Love And Best Wishes has a touching story line and a pleasing country flavor. Ashlie Sweger was chosen to sing this song because of her personal relationship with Parkinson Disease. Being one of her first recording experiences, we thank Ashlie for singing this song. Please enjoy Love And Best Wishes.
Poem: Carol Meenen
Lyrics: Carol Meenen/Andre Clark
Music: Andre Clark
Vocals: Ashlie Sweger
Guest Musicians: Alan Ross, Harmonica - Don Williams, Piano
Click here to sample track
| Wed, 08 Sep 2010 05:00:00 PDT Neurology / Neuroscience TPP Global Development Ltd Enters Into An Agreement With The University Of Edinburgh For Future Drug Development TPP Global Development Ltd (TPP) announced an agreement with the University of Edinburgh to collaborate on the development of novel pre-clinical intellectual property originated within the University. TPP and the University of Edinburgh will focus on commercialisation opportunities in the areas of nervous system disorders, immunology/inflammation and oncology... |
| Wed, 08 Sep 2010 02:00:00 PDT Parkinson's Disease Yeast Holds Clues To Parkinson's Disease Yeast could be a powerful ally in the discovery of new therapeutic drugs to treat Parkinson's disease says a scientist presenting his work at the Society for General Microbiology's autumn meeting in Nottingham today... |
| Tue, 07 Sep 2010 04:00:00 PDT Parkinson's Disease Roche And ReMYND Enter Into A Strategic Alliance To Develop First-In-Class Disease-Modifying Treatments For Parkinson's And Alzheimer's Disease Roche (SIX: RO, ROG; OTCQX: RHHBY) and reMYND announced that they have entered into an agreement to develop novel therapeutics that could slow down neurodegeneration in Parkinson's and Alzheimer's patients by inhibiting α-synuclein and tau toxicity... |
| Mon, 06 Sep 2010 00:00:00 PDT Parkinson's Disease Cognitive Impairment In People With Parkinson's Disease Exposed By Study Queen's researchers have found that people with Parkinson's disease can perform automated tasks better than people without the disease, but have significant difficulty switching from easy to hard tasks. The findings are a step towards understanding the aspects of the illness that affect the brain's ability to function on a cognitive level... |
| Sun, 05 Sep 2010 00:00:00 PDT Parkinson's Disease Santhera And Ipsen Enter Into Licensing Agreement For Fipamezole For The Treatment Of Dyskinesia In Parkinson's Disease Santhera Pharmaceuticals (SIX: SANN) and Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) announced a license agreement for the development and commercialization of fipamezole (antagonist of the adrenergic alpha-2 receptor) for territories outside of North America and Japan... |
| Thu, 02 Sep 2010 01:00:00 PDT Parkinson's Disease New Light On The Mechanism Of Parkinson's Disease A significant number of Parkinson's disease patients have a mutation of the enzyme Leucine-Rich Repeat Protein Kinase 2 (LRRK2, also known as dardarin). However, little is understood about how it is regulated or functions... |
| Sat, 28 Aug 2010 00:00:00 PDT Parkinson's Disease New Parkinson's Gene Is Linked To Immune System A hunt throughout the human genome for variants associated with common, late-onset Parkinson's disease has revealed a new genetic link that implicates the immune system and offers new targets for drug development... |
